Speeches and presentations
Search through our archive of speeches and presentations from conferences and events.
Visit our corporate reporting archive for our Annual Reports.
For quarterly results materials visit quarterly results.
07 September 2023
Citi’s 18th Annual BioPharma Conference
Phil Dormitzer, SVP, Head of Vaccines R&D joined Andrew Baum in a fireside chat at Citi’s 18th Annual BioPharma Conference which took place Thursday, September 7th at 8:50am ET/1:50pm UK.
27 June 2023
Getting ahead of Infectious Disease with GSK management
The virtual event featured a presentation, four breakout sessions and an interactive Q&A. Recordings of all sessions are available on YouTube.
- Watch the recordings
- Opening and plenary session (PDF - 2.6MB)
- Breakout 1 - Seasonal respiratory viruses (PDF - 1.6MB)
- Breakout 2 - Bacterial and fungal infections (PDF - 1.7MB)
- Breakout 3 - Chronic viral infections (PDF - 784.1KB)
- Breakout 4 - Delivering health impact at scale (PDF - 1.8MB)
- Download all
13 June 2023
Goldman Sachs’ 44th Annual Global Healthcare Conference
Tony Wood, Chief Scientific Officer, discussed progress made in R&D during a fireside chat on Tuesday, 13 June at 9:20am PT/12:20pm ET/5:20pm UK during Goldman Sachs’ 44th Annual Global Healthcare Conference, in Dana Point, California.
06 June 2023
ESG Investor Education Event (Clinical Trial Diversity)
During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, provided insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders also provided an overview of GSK’s work to ensure clinical trials reflect the populations most impacted by a disease and explored a HIV case study that demonstrated the power of clinical trial diversity in action. The presentation was followed by an opportunity for audience Q&A.
10 January 2023
41st annual JP Morgan Healthcare Conference
Emma Walmsley, Chief Executive Officer, presented at the 41st annual JP Morgan Healthcare Conference on Tuesday 10 January at 07:30-08:10am PT / 15:30-16:10 GMT. The 40 minute session included a presentation and a moderated Q&A discussion.
30 November 2022
Evercore ISI HealthCONx Conference
Deborah Waterhouse, Chief Executive Officer of ViiV Healthcare, and Dr. Kimberly Smith, Head of R&D at ViiV Healthcare, discussed the progress being made in HIV innovation during a fireside chat at the Evercore ISI HealthCONx Conference Wednesday, November 30th, 1pm UK / 8:00am ET.
16 November 2022
Jefferies London Healthcare Conference
David Redfern, Chief Strategy Officer, participated in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, 16 November 2022 at 09:45 GMT.
28 October 2022
Response to Investor Forum Letter
GSK’s response to an Investor Forum letter, regarding GSK’s redefined operating model post-Demerger.
21 October 2022
Investor science event: Getting ahead of respiratory syncytial virus in older adults
After presenting the positive AReSVi-006 pivotal phase III results for our RSV (respiratory syncytial virus) older adults vaccine candidate at IDWeek 2022, GSK management hosted an investor science event on 21 October 2022.
16 September 2022
BofA 2022 Global Healthcare Conference
Emma Walmsley, CEO, participated in a fireside chat at the BofA Global Healthcare Conference on Friday 16 September at 0815 BST.
